CLMA_0110815_950x150.jpg

Vendor Sponsored Presentations

Grifols 

The Benefits of Blood Group Genotyping
Ghislain Noumsi, MD, SBB (ASCP)
0.75 CEUs 

Monday, March 21, 2016
7:00 a.m. - 7:45 a.m.
Coronado A-C, Disney's Coronado Springs Resort 

Objectives:

  1. Review the principles of molecular testing as applied to blood group typing
  2. Analyze the clinical impact of molecular testing for different groups 
  3. Evaluate the factors determining the cost-effectiveness of molecular testing

The description of the genes encoding the major blood group antigens has allowed for the development of high-throughput molecular testing assays. Such DNA-based assays offer an alternative route for problems routinely encountered in laboratory practice, especially in solving complex serological problems, and providing extended antigenic matched blood for alloimmunized patients. The clinical benefits of blood group genotyping are well-documented; however, for many institutions, assessing the cost-effectiveness of this technique represents a growing paradigm in the decision to fully adopt this strategy. In many instances, decisions have been erroneously based on tagged direct cost of molecular assays (equipment, materials, and reagents), omitting the benefit in reducing indirect and societal costs. This presentation will review the principle of blood genotyping -- its clinical applications -- and will provide a holistic analysis of factors contributing to the cost-effectiveness of this technique based on data available from the literature.

Register for Grifols’ Vendor Sponsored Presentation in the KnowledgeLab 2016 registration process. If you have already registered, go back to edit your registration and add the session to your reservation. There is no charge for the Vendor Sponsored Presentation.

Alexion 

Low ALP Matters:  Alkaline Phosphatase, Why It’s Important, and Its Role in the Diagnosis of Hypophosphatasia
Bryan McGee, PharmD, MBA
0.75 CEUs 

Tuesday, March 22, 2016
7:00 a.m. - 7:45 a.m.
Coronado A-C, Disney's Coronado Springs Resort 

Low alkaline phosphatase (ALP) is the biochemical hallmark of Hypophosphatasia, a serious, life-threatening metabolic bone disease affecting infants, children, and adults. However, diagnosis is challenging due to the lack of updated pediatric ALP reference ranges and attention to low ALP. Data such as CALIPER can be a solution to this problem.


Learning outcomes:

  1. Understand how current ALP pediatric reference ranges (RRs) in use today hinder timely and accurate diagnosis of HPP
  2. Understand how updated ALP pediatric RR data such as CALIPER can support timely and accurate diagnosis of HPP
  3. Understand how to implement CALIPER ALP RR data in your lab

Register for Alexion’s Vendor Sponsored Presentation in the KnowledgeLab 2016 registration process. If you have already registered, go back to edit your registration and add the session to your reservation. There is no charge for the Vendor Sponsored Presentation.